- Organization name
- UDI-DI code
- Reference / catalog number
SE-MF-000014170No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.ImmunoCAP Rapid Developer Solution Pipette is an EU IVDR-regulated in vitro diagnostic registered in EUDAMED. It is classified as IVDR Class A. Manufactured by Phadia AB. Placed on the EU market in Sweden. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Mar 25, 2026
7333066BUDI0039M9Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
(01)07333066017655
The compliance carrier: encodes the device identifier plus the production identifiers (lot, serial, dates) registered for this device.
1 warning recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Sweden; available across 14 countries total.
| Country | On market since | Until |
|---|---|---|
| SwedenPrimary placement | — | Still on market |
| Austria | Sep 13, 2005 | Still on market |
| Cyprus | Sep 13, 2005 | Still on market |
| Germany | Sep 13, 2005 | Still on market |
| Denmark | Sep 13, 2005 | Still on market |
| Spain | Sep 13, 2005 | Still on market |
| Finland | Sep 13, 2005 | Still on market |
| France | Sep 13, 2005 | Still on market |
| Ireland | Sep 13, 2005 | Still on market |
| Iceland | Sep 13, 2005 | Still on market |
| Liechtenstein | Sep 13, 2005 | Still on market |
| Luxembourg | Sep 13, 2005 | Still on market |
| Malta | Sep 13, 2005 | Still on market |
| Norway | Sep 13, 2005 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
07333066017655Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
7333066BUDI0039M982-1004-01UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01029003BUFFERS (UNASSIGNABLE), SUPPLEM. REAGENTS, ETC (IC)No certificate specifically references this device's Basic UDI-DI.
7333066BUDI0070M3On the marketImmunoCAP Rapid Blood Sampling Device7333066BUDI0039M9On the marketImmunoCAP Rapid Developer Solution7333066BUDI0041LUOn the marketImmunoCAP Rare Allergen e203, Mink epithelium7333066BUDI0019M3On the marketImmunoCAP Rare Allergen e206, Rabbit serum proteins7333066BUDI0017LXOn the marketImmunoCAP Rare Allergen e208, Chinchilla epithelium7333066BUDI0017LXOn the market